NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test) |
|||
| UNCOV-40 | Atlas Link Technology | 40 Tests | EUR 115 |
Human IgG antibody Laboratories manufactures the sars antibody test results blood test reagents distributed by Genprice. The Sars Antibody Test Results Blood Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Sars products are available in stock. Specificity: Sars Category: Antibody Group: Test Results
Cpn (Chlamydia Pneumoniae Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of Cpn (Chlamydia Pneumoniae Antibody IgG) |
||
AOA (Anti-ovary Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of AOA (Anti-ovary Antibody IgG) |
||
EM (Anti-endometrial Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of EM (Anti-endometrial Antibody IgG) |
||
ASA (Anti-sperm Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of ASA (Anti-sperm Antibody IgG) |
||
Mg (Mycoplasma Genitalium Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of Mg (Mycoplasma Genitalium Antibody IgG) |
||
Mh (Mycoplasma Hominis Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of Mh (Mycoplasma Hominis Antibody IgG) |
||
Ct (Chlamydia Trachomatis Antibody IgG) ELISA test |
||
| Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of Ct (Chlamydia Trachomatis Antibody IgG) |
||
TruStrip RDT Zaire Ebola Virus antigen (GP) rapid test (visual results in 2-10 mins), 10 cassettes/pk |
|||
| AE-320805-RDT-10 | Alpha Diagnostics | 1 pk | EUR 343.2 |
TruStrip RDT Human Anti-Zaire Ebola virus glycoprotein (GP) antibody rapid test (visual results in 2-10 min), 10 cassettes/pk |
|||
| AE-320625-RDT | Alpha Diagnostics | 1 pk | EUR 351.6 |
TruStrip RDT Beta-Lactam and Tetracyclines rapid test strips, results is 2-10 mins, 50 strips/pk |
|||
| DE-100260-RDT | Alpha Diagnostics | 1 pk | Ask for price |
TruStrip RDT Canine distemper virus (hardpad disease) antigen rapid test card, results is 2-10 mins, 50 cards/pk |
|||
| RV-501200-RDT | Alpha Diagnostics | 1 pk | Ask for price |
TruStrip RDT Humanized Ebola IgG (humanized IgGs expressed in tobacco or other plants) rapid test (results in 2-10 min), 25 cassettes/pk |
|||
| AE-320880-RDT-25 | Alpha Diagnostics | 1 pk | EUR 351.6 |
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
| GEN-B352-20tests | Accu test | 20 tests | EUR 283.2 |
|
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
|||
Accu-Tell COVID-19 IgG/IgM Rapid Test |
|||
| GEN-B352-40tests | Accu test | 40 tests | EUR 385.2 |
|
Description: A rapid test for detection of antibodies (IgG and IgM) for 2019-nCoV, the novel Coronavirus from the Wuhan strain. The test is easy to perform, takes 10 minutes to provide reliable results and is higly specific to the 2019-nCoV Coronavirus. |
|||
anti- SARS antibody |
|||
| FNab07609 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SARS |
|||
SARS-CoV-2 Antigen Rapid Test Kit |
|||
| CoV2Ag-1 | UnScience | 1T | EUR 9.6 |
|
Description: This kit adopts the sandwich method and the technical principle of colloidal gold immunochromatography to qualitative determine the SARS-CoV-2 antigen. During the test, the sample is dropped into the sample well, and chromatography is performed under the capillary effect. The SARS-CoV-2 antigen in the sample combined with the colloidal goldlabeled SARS-CoV-2 monoclonal antibody I, and then spread to the test area. It is captured by another coated antibody (SARS-CoV-2 monoclonal antibody II), to form a complex and gather in the test area (T line). The quality control area is coated with the goat antimouse antibody, and the colloidal gold-labeled antibody is captured to form a complex and aggregate in the quality control area (C line). If the C line does not show color, it indicates that the result is invalid, and this sample needs to be tested again. |
|||
SARS-CoV-2 Antigen Rapid Test Kit |
|||
| CoV2Ag-25 | UnScience | 25T/kit | EUR 42 |
|
Description: This product is used for in vitro qualitative detection of SARS-CoV-2 antigen in human oropharyngeal swabs, nasal swabs and nasopharyngeal swabs. It is helpful as an aid in the screening of early mild, asymptomatic, or acute patients for identification of SARS-CoV-2 infection. |
|||
SARS-CoV-2 Rapid Antigen Test Nasal |
|||
| 9901-NCOV-03G | Roche Diagnostics | 25 Tests/Kit | EUR 112.8 |
|
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke |
|||
NOVATest IgG/IgM Antibody Rapid Test Kit (NOVA Test) |
|||
| UNCOV-40 | Atlas Link Technology | 40 Tests | EUR 115 |
Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) |
|||
| IOV87952 | INVBIO | 20T/kit | EUR 46.8 |
|
Description: Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva) is an in vitro diagnostic test for the qualitative detection of novel coronavirus antigens in human saliva, using the rapid immunochromatographic method. The identification is based on the monoclonal antibodies specific for the novel coronvirus antigen. It will provide information for clinical doctors to prescribe correct medications. |
|||
Recombinant human Blood group Rh(D) polypeptide |
|||
| P1959 | FN Test | 100ug | Ask for price |
|
Description: Recombinant protein for human Blood group Rh(D) polypeptide |
|||
Syphilis Antibody ELISA test |
|||
| 100 | Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of Syphilis Antibody |
|||
anti- SARS2 antibody |
|||
| FNab07610 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against SARS2 |
|||
HAV antibody IgM ELISA test |
|||
| 75 | Biobase | 96T/Box | Ask for price |
|
Description: ELISA based test for quantitative detection of HAV antibody IgM |
|||